7 December 2018
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.
Arjen Blom will focus on novel tools for imaging of early cartilage destruction for diagnostic purposes in rheumatic diseases.
Peter van Lent will focus on the therapeutic efficacy of fat derived stem cells in dampening synovitis and development of joint destruction in posttraumatic OA.
Two projects of Arjen Blom and Peter van Lent, theme Inflammatory diseases, were granted by the Dutch Arthritis Association (ReumaNederland) (€ 160,000 per project).
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.
Arjen Blom will focus on novel tools for imaging of early cartilage destruction for diagnostic purposes in rheumatic diseases.
Peter van Lent will focus on the therapeutic efficacy of fat derived stem cells in dampening synovitis and development of joint destruction in posttraumatic OA.
-
Want to know more about these subjects? Click on the buttons below for more news.